Policy
Filling the Gaps in Surface Cleaning and Disinfection
It’s time to write or update the policies and procedures for cleaning and disinfection in your cleanroom suites, as described in the latest edition of USP General Chapter <797>, as well as guidance from the FDA and regulatory agencies.
AUGUST 22, 2025
Making Surface/Air Sampling Data Work for You
Viable air and surface sampling in the home infusion pharmacy cleanroom is a tool for understanding what is happening in your cleanroom environment and driving process improvement—not just a “pass” or “no pass” checklist.
AUGUST 22, 2025
Can Manufacturer and Payor Incentives Align?
Pharmaceutical payors generally seek quick evidence that a drug is improving health outcomes, while drug manufacturers often stress that their medications work best over many years. Managing these clashing incentives and perspectives was a topic at Asembia’s AXS25 Summit.
AUGUST 21, 2025
Legislation, Manufacturer Campaigns Buffet 340B Program
At the 2025 340B Winter Coalition Conference, discussions, policy updates and industry trends provided valuable insights into the program's future.
AUGUST 20, 2025
Inflation Reduction Act ‘Ripple Effect’ Imperils Medicare Drug Access
The inflation Reduction Act of 2022 has triggered an unintended consequence—significantly declining coverage of competitive drug classes.
AUGUST 19, 2025
A Pledge for More Streamlined Prior Authorizations
Stakeholders from federal health agencies and leading payors have pledged to streamline the often burdensome prior authorization process that can lead to delays in treatment and poorer clinical outcomes.
AUGUST 19, 2025
New Biosimilars Metric Confirms Efficacy Of Adalimumab Switch
Most patients who were switched from adalimumab to an interchangeable biosimilar experienced clinical success, with the vast majority remaining on a biosimilar three months after conversion, according to a study presented at the ASHP Pharmacy Futures 2025 meeting.
AUGUST 18, 2025
Will the IRA Harm the Financial Integrity of LTCs?
Changes to Medicare Part D reimbursement policies could lower operating margins for long-term care pharmacies.
AUGUST 12, 2025
ASHP Report: Some Generic Drugs A Persistent Source of Rx Shortages
Active drug shortages in the United States are down from an all-time high of 323 in early 2024. However, a new ASHP report reveals that shortages remain stubbornly high, with 270 reported through the first quarter of 2025.
JULY 23, 2025
HHS and Private Health Insurers Team Up to Improve Prior Authorization Process
Stakeholders from federal health agencies and leading payors have pledged to streamline the often burdensome prior authorization process that can lead to delayed treatment and poorer clinical outcomes.
JULY 14, 2025
New Administration’s Impact on 340B Program: TBD
How could the second Trump administration affect the federal 340B Drug Pricing Program? It’s yet to be determined, according to policy experts.
JULY 2, 2025
USPSTF: Prevent Tragic Outcomes by Universal Syphilis Screening During Pregnancy
The U.S. Preventive Services Task Force is continuing to recommend early, universal syphilis screening during pregnancy.
JULY 1, 2025
